We are pleased to announce a new clinical trial collaboration with Roche to evaluate SRF388 in combination with atezolizumab and bevacizumab in patients with treatment-naïve liver cancer: https://t.co/F8xKyDv4k2 https://t.co/HM7cFVK2H0
We are pleased to announce a new clinical trial collaboration with Roche to evaluate SRF388 in combination with atezolizumab and bevacizumab in patients with treatment-naïve liver cancer: https://t.co/F8xKyDv4k2 https://t.co/HM7cFVK2H0